|

Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

RECRUITINGSponsored by M.D. Anderson Cancer Center
Actively Recruiting
SponsorM.D. Anderson Cancer Center
Started2024-07-10
Est. completion2035-12-28
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06377527

Summary

To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Adult patients over the age of 18.
2. Patients with a diagnosis of gynecologic mesonephric-like adenocarcinoma (MLA), mesonephric adenocarcinoma (MA), mesonephric carcinosarcoma, or mesonephric-like carcinosarcomas.
3. For patients who provide consent, they must speak and/or read English or Spanish.

Exclusion Criteria:

1. Patients with other subtypes of EACs.
2. Patients who are considered cognitively impaired. Assessment will be obtained based on their need of a Legally Authorized Representative.

Conditions2

CancerMesonephric-like Adenocarcinoma

Locations1 site

MD Anderson Cancer Center
Houston, Texas, 77030
Jeffrey How, MD

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.